Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.

about

Inflammation in IgA nephropathy.Albuminuria during treatment with angiotensin type II receptor blocker is a predictor for GFR decline among non-diabetic hypertensive CKD patients

P2860

Q39178756-78D2C699-827E-4A18-9C7C-13642E997345 Q58701697-CA664EFF-4EFB-4CF1-83F9-268885BC1035

P2860

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.

Item

http://www.wikidata.org/entity/Q36077744

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.

@ast

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.

@en

type

Item

label

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.

@ast

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.

@en

prefLabel

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.

@ast

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.

@en

P1476

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.

@en

P2093

Antonello Pani

http://www.w3.org/2001/XMLSchema#string

Bianca Visciano

http://www.w3.org/2001/XMLSchema#string

Claudio Pozzi

http://www.w3.org/2001/XMLSchema#string

Cristina Sarcina

http://www.w3.org/2001/XMLSchema#string

Enzo Corghi

http://www.w3.org/2001/XMLSchema#string

Francesca Ferrario

http://www.w3.org/2001/XMLSchema#string

Gaia Santagostino

http://www.w3.org/2001/XMLSchema#string

Ilaria De Simone

http://www.w3.org/2001/XMLSchema#string

Lucia Del Vecchio

http://www.w3.org/2001/XMLSchema#string

Silvia Furiani

http://www.w3.org/2001/XMLSchema#string

P2860

Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors.

Predicting progression in IgA nephropathy.

Corticosteroid therapy in IgA nephropathy.

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.

P304

e0158584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0158584

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carmine Tinelli

Annalisa De Silvestri

P577

2016-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27416024

http://www.w3.org/2001/XMLSchema#string

P932

4945016

http://www.w3.org/2001/XMLSchema#string

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.

about

P2860

P2860

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932